发明名称 HIGH ISOMEROHYDROLASE ACTIVITY MUTANTS OF MAMMALIAN RPE65
摘要 Mutant mammalian RPE65 proteins and portions thereof, and nucleic acids encoding the mutants, for use in treating a condition related to retinal degeneration in a subject, the mutant mammalian RPE65 proteins or portions thereof having isomerohydrolase activity. A gene therapy method of treating a condition related to retinal degeneration in a mammalian subject in need of such treatment, comprising administering to the subject a therapeutically- effective amount of a vector comprising a nucleic acid encoding a mutant mammalian RPE65 protein or a portion thereof. A method of treating a condition related to retinal degeneration in a subject in need of such treatment, comprising administering to the subject a therapeutically-effective amount of at least one of a mutant mammalian RPE65 protein or a portion thereof.
申请公布号 SG11201700724P(A) 申请公布日期 2017.02.27
申请号 SG11201700724P 申请日期 2015.07.27
申请人 THE BOARD OF REGENTS OF THE UNIVERSITY OF OKLAHOMA 发明人 MA, JIAN-XING;TAKAHASHI, YUSUKE;MOISEYEV, GENNADIY
分类号 A61K48/00;A01N63/00 主分类号 A61K48/00
代理机构 代理人
主权项
地址